414 related articles for article (PubMed ID: 24675922)
1. How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis.
Puig I; Calvet X; Baylina M; Isava Á; Sort P; Llaó J; Porta F; Vida F
PLoS One; 2014; 9(3):e92922. PubMed ID: 24675922
[TBL] [Abstract][Full Text] [Related]
2. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
3. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
Li X; Tao LP; Wang CH
World J Gastroenterol; 2014 Sep; 20(34):12322-9. PubMed ID: 25232268
[TBL] [Abstract][Full Text] [Related]
6. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
Shen C; Shi Y; Liang T; Su P
Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis.
Hou YC; Hu Q; Huang J; Fang JY; Xiong H
Sci Rep; 2017 Apr; 7():46650. PubMed ID: 28440297
[TBL] [Abstract][Full Text] [Related]
8. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis.
Liu L; Li C; Huang Y; Jin H
J Gastrointest Surg; 2019 Oct; 23(10):1991-2001. PubMed ID: 30251071
[TBL] [Abstract][Full Text] [Related]
10. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
11. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug effectivity in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis.
Serrano JPR; Jukemura J; Romanini SG; Aguilar PFG; de Castro JSL; Torres IT; Pulla JAS; Neto OM; Taglieri E; Ardengh JC
World J Gastrointest Endosc; 2020 Nov; 12(11):469-487. PubMed ID: 33269056
[TBL] [Abstract][Full Text] [Related]
14. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis.
Dubravcsik Z; Hritz I; Keczer B; Novák P; Lovász BD; Madácsy L
Pancreatology; 2021 Jun; 21(4):704-713. PubMed ID: 33926821
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis.
Du F; Zhang Y; Yang X; Zhang L; Yuan W; Fan H; Ren L
J Gastrointest Surg; 2022 Sep; 26(9):1982-1997. PubMed ID: 35680777
[TBL] [Abstract][Full Text] [Related]
16. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
Wan J; Ren Y; Zhu Z; Xia L; Lu N
BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
[TBL] [Abstract][Full Text] [Related]
17. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
Rustagi T; Njei B
Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
[TBL] [Abstract][Full Text] [Related]
18. The Incidence and Severity of Post-ERCP Pancreatitis in Patients Receiving Standard Administration of NSAIDs: a Systematic Review and Meta-analysis.
Kang X; Guo X; Chen Z; Zhou Z; Luo H; Lu Y; Lou L; Guo X; Pan Y
J Gastrointest Surg; 2022 Nov; 26(11):2380-2389. PubMed ID: 35941494
[TBL] [Abstract][Full Text] [Related]
19. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.
Ding X; Chen M; Huang S; Zhang S; Zou X
Gastrointest Endosc; 2012 Dec; 76(6):1152-9. PubMed ID: 23164513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
